Blocking immune regulators can boost immune responses to existing tumors

Monoclonal antibodies that bind to CD8 molecules are utilized in immunotherapy for cancer treatment

Polyclonal antibodies are employed in immunotherapy

Monoclonal antibodies derived from mice do not trigger hypersensitivity reactions in humans

Monoclonal antibodies targeting autoimmune-associated HLA-DR4 molecules, either alone or conjugated with toxins, can inhibit tumor growth